## PART 1 of 5 — Concept Review
Questions (Not a Test Bank, Not a
Substitute for Publisher Materials)
### Psychiatric-Mental Health Nurse
Practitioner (PMHNP) Program
**Program:** Psychiatric-Mental Health Nurse Practitioner (PMHNP) —
DNP/graduate-level preparation
**Certification Alignment:** ANCC Psychiatric-Mental Health Nurse
Practitioner (Across the Lifespan) Board Certification; AANPCB PMHNP
Certification
**Test Content Outline Domains Covered Across Parts:** Scientific Foundation
(22%), Advanced Practice Skills (27%), Diagnosis and Treatment (22%),
Psychotherapy and Related Therapies (11%),
Ethical/Legal/Cultural/Professional Issues (17%)
**Part Coverage:** Part 1 — Scientific Foundation (Neuroanatomy,
Neurophysiology, Psychopharmacology Foundations, Psychopathology,
Developmental Theory, Cultural and Social Foundations)
**Questions:** 1–70
.
---
## SECTION 1: NEUROANATOMY AND NEUROPHYSIOLOGY —
Questions 1–18
**1. A PMHNP student is analyzing the neurobiology of schizophrenia. Which
dopaminergic pathway is most directly associated with the positive symptoms
of schizophrenia?**
A. Mesocortical pathway
,B. Mesolimbic pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
**Correct Answer: B**
**Rationale:** Hyperactivity of dopamine in the mesolimbic pathway is most
directly associated with positive symptoms (hallucinations, delusions,
disorganized thinking). Option A (mesocortical) is associated with negative
symptoms and cognitive deficits (hypoactivity). Option C (nigrostriatal) is
associated with movement disorders and extrapyramidal symptoms. Option D
(tuberoinfundibular) is associated with prolactin regulation. Understanding
these four pathways guides antipsychotic selection and side-effect anticipation.
---
**2. A PMHNP is assessing a patient starting a first-generation antipsychotic.
Which dopaminergic pathway blockade is most directly responsible for
extrapyramidal symptoms (EPS)?**
A. Mesolimbic pathway
B. Mesocortical pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
**Correct Answer: C**
**Rationale:** Blockade of dopamine in the nigrostriatal pathway causes EPS
(dystonia, akathisia, parkinsonism, tardive dyskinesia). Option A (mesolimbic)
mediates antipsychotic effect. Option B (mesocortical) relates to
,negative/cognitive symptoms. Option D (tuberoinfundibular) blockade causes
hyperprolactinemia. Knowing which pathway mediates which effect guides
clinical monitoring.
---
**3. A patient on risperidone reports galactorrhea and amenorrhea. Which
dopaminergic pathway is most directly involved?**
A. Mesolimbic
B. Mesocortical
C. Nigrostriatal
D. Tuberoinfundibular
**Correct Answer: D**
**Rationale:** Blockade of the tuberoinfundibular pathway disinhibits
prolactin release from the anterior pituitary, causing hyperprolactinemia with
galactorrhea, amenorrhea, and sexual dysfunction. Options A, B, and C do not
directly regulate prolactin. Recognizing this pathway guides selection of
prolactin-sparing antipsychotics (e.g., aripiprazole, quetiapine).
---
**4. A PMHNP is reviewing the neurobiology of depression. Which monoamine
hypothesis best accounts for the delayed therapeutic effect of SSRIs (2–4
weeks) despite immediate serotonin reuptake inhibition?**
A. Monoamine depletion hypothesis
B. Receptor downregulation and neuroplasticity hypothesis
, C. Dopamine dysregulation hypothesis
D. Glutamate excitotoxicity hypothesis
**Correct Answer: B**
**Rationale:** The delayed therapeutic effect is best explained by
downstream adaptations — serotonin receptor downregulation and enhanced
neuroplasticity (BDNF, hippocampal neurogenesis) — rather than immediate
reuptake inhibition. Option A describes the original monoamine hypothesis but
does not explain the delay. Options C and D address other mechanisms. This
concept guides patient education about expected response time.
---
**5. Which brain structure is most directly associated with fear conditioning
and is a target in the treatment of anxiety disorders?**
A. Amygdala
B. Hippocampus
C. Prefrontal cortex
D. Basal ganglia
**Correct Answer: A**
**Rationale:** The amygdala mediates fear conditioning, threat detection,
and emotional salience, and is a key target in anxiety disorders. Option B
(hippocampus) mediates memory and is implicated in PTSD and depression.
Option C (prefrontal cortex) mediates executive function and is hypoactive in
PTSD and depression. Option D (basal ganglia) mediates movement and is
implicated in OCD. Understanding these structures guides treatment
Rationale.
Questions (Not a Test Bank, Not a
Substitute for Publisher Materials)
### Psychiatric-Mental Health Nurse
Practitioner (PMHNP) Program
**Program:** Psychiatric-Mental Health Nurse Practitioner (PMHNP) —
DNP/graduate-level preparation
**Certification Alignment:** ANCC Psychiatric-Mental Health Nurse
Practitioner (Across the Lifespan) Board Certification; AANPCB PMHNP
Certification
**Test Content Outline Domains Covered Across Parts:** Scientific Foundation
(22%), Advanced Practice Skills (27%), Diagnosis and Treatment (22%),
Psychotherapy and Related Therapies (11%),
Ethical/Legal/Cultural/Professional Issues (17%)
**Part Coverage:** Part 1 — Scientific Foundation (Neuroanatomy,
Neurophysiology, Psychopharmacology Foundations, Psychopathology,
Developmental Theory, Cultural and Social Foundations)
**Questions:** 1–70
.
---
## SECTION 1: NEUROANATOMY AND NEUROPHYSIOLOGY —
Questions 1–18
**1. A PMHNP student is analyzing the neurobiology of schizophrenia. Which
dopaminergic pathway is most directly associated with the positive symptoms
of schizophrenia?**
A. Mesocortical pathway
,B. Mesolimbic pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
**Correct Answer: B**
**Rationale:** Hyperactivity of dopamine in the mesolimbic pathway is most
directly associated with positive symptoms (hallucinations, delusions,
disorganized thinking). Option A (mesocortical) is associated with negative
symptoms and cognitive deficits (hypoactivity). Option C (nigrostriatal) is
associated with movement disorders and extrapyramidal symptoms. Option D
(tuberoinfundibular) is associated with prolactin regulation. Understanding
these four pathways guides antipsychotic selection and side-effect anticipation.
---
**2. A PMHNP is assessing a patient starting a first-generation antipsychotic.
Which dopaminergic pathway blockade is most directly responsible for
extrapyramidal symptoms (EPS)?**
A. Mesolimbic pathway
B. Mesocortical pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
**Correct Answer: C**
**Rationale:** Blockade of dopamine in the nigrostriatal pathway causes EPS
(dystonia, akathisia, parkinsonism, tardive dyskinesia). Option A (mesolimbic)
mediates antipsychotic effect. Option B (mesocortical) relates to
,negative/cognitive symptoms. Option D (tuberoinfundibular) blockade causes
hyperprolactinemia. Knowing which pathway mediates which effect guides
clinical monitoring.
---
**3. A patient on risperidone reports galactorrhea and amenorrhea. Which
dopaminergic pathway is most directly involved?**
A. Mesolimbic
B. Mesocortical
C. Nigrostriatal
D. Tuberoinfundibular
**Correct Answer: D**
**Rationale:** Blockade of the tuberoinfundibular pathway disinhibits
prolactin release from the anterior pituitary, causing hyperprolactinemia with
galactorrhea, amenorrhea, and sexual dysfunction. Options A, B, and C do not
directly regulate prolactin. Recognizing this pathway guides selection of
prolactin-sparing antipsychotics (e.g., aripiprazole, quetiapine).
---
**4. A PMHNP is reviewing the neurobiology of depression. Which monoamine
hypothesis best accounts for the delayed therapeutic effect of SSRIs (2–4
weeks) despite immediate serotonin reuptake inhibition?**
A. Monoamine depletion hypothesis
B. Receptor downregulation and neuroplasticity hypothesis
, C. Dopamine dysregulation hypothesis
D. Glutamate excitotoxicity hypothesis
**Correct Answer: B**
**Rationale:** The delayed therapeutic effect is best explained by
downstream adaptations — serotonin receptor downregulation and enhanced
neuroplasticity (BDNF, hippocampal neurogenesis) — rather than immediate
reuptake inhibition. Option A describes the original monoamine hypothesis but
does not explain the delay. Options C and D address other mechanisms. This
concept guides patient education about expected response time.
---
**5. Which brain structure is most directly associated with fear conditioning
and is a target in the treatment of anxiety disorders?**
A. Amygdala
B. Hippocampus
C. Prefrontal cortex
D. Basal ganglia
**Correct Answer: A**
**Rationale:** The amygdala mediates fear conditioning, threat detection,
and emotional salience, and is a key target in anxiety disorders. Option B
(hippocampus) mediates memory and is implicated in PTSD and depression.
Option C (prefrontal cortex) mediates executive function and is hypoactive in
PTSD and depression. Option D (basal ganglia) mediates movement and is
implicated in OCD. Understanding these structures guides treatment
Rationale.
